| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA nuclease activity | 6.51e-06 | 136 | 39 | 5 | GO:0004540 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.68e-05 | 79 | 39 | 4 | GO:0004521 | |
| GeneOntologyMolecularFunction | 5'-3' RNA exonuclease activity | 2.22e-05 | 4 | 39 | 2 | GO:0004534 | |
| GeneOntologyMolecularFunction | piRNA binding | 5.55e-05 | 6 | 39 | 2 | GO:0034584 | |
| GeneOntologyMolecularFunction | nuclease activity | 8.29e-05 | 231 | 39 | 5 | GO:0004518 | |
| GeneOntologyMolecularFunction | endonuclease activity | 1.41e-04 | 136 | 39 | 4 | GO:0004519 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 1.46e-04 | 417 | 39 | 6 | GO:0140098 | |
| GeneOntologyMolecularFunction | 5'-3' exonuclease activity | 5.58e-04 | 18 | 39 | 2 | GO:0008409 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 1.46e-03 | 645 | 39 | 6 | GO:0140640 | |
| GeneOntologyCellularComponent | T cell receptor complex | 3.47e-04 | 163 | 43 | 4 | GO:0042101 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 7.30e-04 | 350 | 43 | 5 | GO:0098802 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 1.02e-03 | 785 | 43 | 7 | GO:0098797 | |
| GeneOntologyCellularComponent | pole plasm | 1.62e-03 | 29 | 43 | 2 | GO:0045495 | |
| GeneOntologyCellularComponent | germ plasm | 1.62e-03 | 29 | 43 | 2 | GO:0060293 | |
| GeneOntologyCellularComponent | perinuclear endoplasmic reticulum | 1.62e-03 | 29 | 43 | 2 | GO:0097038 | |
| GeneOntologyCellularComponent | P granule | 1.62e-03 | 29 | 43 | 2 | GO:0043186 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 2.23e-03 | 269 | 43 | 4 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 2.82e-03 | 287 | 43 | 4 | GO:0035770 | |
| Domain | PIWI | 1.00e-04 | 8 | 36 | 2 | PS50822 | |
| Domain | Piwi | 1.00e-04 | 8 | 36 | 2 | IPR003165 | |
| Domain | Piwi | 1.00e-04 | 8 | 36 | 2 | PF02171 | |
| Domain | Piwi | 1.00e-04 | 8 | 36 | 2 | SM00950 | |
| Domain | PAZ | 1.29e-04 | 9 | 36 | 2 | PS50821 | |
| Domain | PAZ_dom | 1.29e-04 | 9 | 36 | 2 | IPR003100 | |
| Domain | PAZ | 1.29e-04 | 9 | 36 | 2 | PF02170 | |
| Domain | PAZ | 1.29e-04 | 9 | 36 | 2 | SM00949 | |
| Domain | - | 3.70e-03 | 47 | 36 | 2 | 3.30.420.10 | |
| Domain | Glycoside_hydrolase_SF | 4.68e-03 | 53 | 36 | 2 | IPR017853 | |
| Domain | RNaseH-like_dom | 7.81e-03 | 69 | 36 | 2 | IPR012337 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 12833571 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 1936125 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 3100621 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 15219549 | ||
| Pubmed | Amino acid sequence of the light chain variable region from a mouse anti-digoxin hybridoma antibody. | 1.49e-06 | 2 | 43 | 2 | 6404298 | |
| Pubmed | Nucleotide sequences of the variable regions of a mouse monoclonal antibody MRK16. | 1.49e-06 | 2 | 43 | 2 | 2110659 | |
| Pubmed | Structural and affinity studies of IgM polyreactive natural autoantibodies. | 1.49e-06 | 2 | 43 | 2 | 8993018 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 24509249 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 2263605 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 15522311 | ||
| Pubmed | 1.68e-06 | 19 | 43 | 3 | 29941866 | ||
| Pubmed | PON2 ameliorates Ang II-induced cardiomyocyte injury by targeting the CANX/NOX4 signaling pathway. | 4.48e-06 | 3 | 43 | 2 | 36840500 | |
| Pubmed | The induction of H3K9 methylation by PIWIL4 at the p16Ink4a locus. | 4.48e-06 | 3 | 43 | 2 | 17544373 | |
| Pubmed | Cell-type-specific translational control of spatial working memory by the cap-binding protein 4EHP. | 4.48e-06 | 3 | 43 | 2 | 36650535 | |
| Pubmed | Piwi genes are dispensable for normal hematopoiesis in mice. | 4.48e-06 | 3 | 43 | 2 | 24058407 | |
| Pubmed | Characterization of the interactions between mammalian PAZ PIWI domain proteins and Dicer. | 8.94e-06 | 4 | 43 | 2 | 14749716 | |
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 20940137 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 20534472 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 17023586 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 25238487 | ||
| Pubmed | Roles of MIWI, MILI and PLD6 in small RNA regulation in mouse growing oocytes. | 2.23e-05 | 6 | 43 | 2 | 28115634 | |
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 26669262 | ||
| Pubmed | Mili interacts with tudor domain-containing protein 1 in regulating spermatogenesis. | 4.16e-05 | 8 | 43 | 2 | 19345100 | |
| Pubmed | Tdrkh is essential for spermatogenesis and participates in primary piRNA biogenesis in the germline. | 4.16e-05 | 8 | 43 | 2 | 23714778 | |
| Pubmed | Identification of eight members of the Argonaute family in the human genome. | 5.35e-05 | 9 | 43 | 2 | 12906857 | |
| Pubmed | Expression of the homeodomain transcription factor Meis2 in the embryonic and postnatal retina. | 5.35e-05 | 9 | 43 | 2 | 17729288 | |
| Pubmed | 6.68e-05 | 10 | 43 | 2 | 20547853 | ||
| Pubmed | 6.68e-05 | 10 | 43 | 2 | 19584108 | ||
| Pubmed | Neurod6 expression defines new retinal amacrine cell subtypes and regulates their fate. | 9.78e-05 | 12 | 43 | 2 | 21743471 | |
| Pubmed | Molecular and Neural Functions of Rai1, the Causal Gene for Smith-Magenis Syndrome. | 9.78e-05 | 12 | 43 | 2 | 27693255 | |
| Pubmed | Cytoplasmic compartmentalization of the fetal piRNA pathway in mice. | 9.78e-05 | 12 | 43 | 2 | 20011505 | |
| Pubmed | Otx2 homeobox gene controls retinal photoreceptor cell fate and pineal gland development. | 1.35e-04 | 14 | 43 | 2 | 14625556 | |
| Pubmed | Differentially expressed genes in the testicular tissues of adenylyl cyclase 3 knockout mice. | 1.55e-04 | 15 | 43 | 2 | 27864010 | |
| Pubmed | The RNA helicase MOV10L1 binds piRNA precursors to initiate piRNA processing. | 1.55e-04 | 15 | 43 | 2 | 25762440 | |
| Pubmed | Mouse MAELSTROM: the link between meiotic silencing of unsynapsed chromatin and microRNA pathway? | 1.77e-04 | 16 | 43 | 2 | 16787967 | |
| Pubmed | Prdm13 is required for Ebf3+ amacrine cell formation in the retina. | 1.77e-04 | 16 | 43 | 2 | 29258872 | |
| Pubmed | BARHL2 differentially regulates the development of retinal amacrine and ganglion neurons. | 1.77e-04 | 16 | 43 | 2 | 19339595 | |
| Pubmed | Pten Regulates Retinal Amacrine Cell Number by Modulating Akt, Tgfβ, and Erk Signaling. | 2.26e-04 | 18 | 43 | 2 | 27605619 | |
| Pubmed | 2.26e-04 | 18 | 43 | 2 | 20399194 | ||
| Pubmed | 2.80e-04 | 20 | 43 | 2 | 10427970 | ||
| Pubmed | Runx1 expression defines a subpopulation of displaced amacrine cells in the developing mouse retina. | 2.80e-04 | 20 | 43 | 2 | 16026391 | |
| Pubmed | Subtype specification of GABAergic amacrine cells by the orphan nuclear receptor Nr4a2/Nurr1. | 3.09e-04 | 21 | 43 | 2 | 19692620 | |
| Pubmed | 3.09e-04 | 21 | 43 | 2 | 25995483 | ||
| Pubmed | Tfap2a and 2b act downstream of Ptf1a to promote amacrine cell differentiation during retinogenesis. | 3.72e-04 | 23 | 43 | 2 | 25966682 | |
| Pubmed | 4.05e-04 | 24 | 43 | 2 | 20826655 | ||
| Pubmed | 4.92e-04 | 124 | 43 | 3 | 8188290 | ||
| Pubmed | Intestinal NCoR1, a regulator of epithelial cell maturation, controls neonatal hyperbilirubinemia. | 5.14e-04 | 27 | 43 | 2 | 28167773 | |
| Pubmed | 5.14e-04 | 27 | 43 | 2 | 20564261 | ||
| Pubmed | 5.93e-04 | 29 | 43 | 2 | 21383078 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 6.25e-04 | 1201 | 43 | 7 | 35696571 | |
| Pubmed | 6.35e-04 | 30 | 43 | 2 | 30127719 | ||
| Pubmed | 6.35e-04 | 30 | 43 | 2 | 29137925 | ||
| Pubmed | Maf1 controls retinal neuron number by both RNA Pol III- and Pol II-dependent mechanisms. | 6.79e-04 | 31 | 43 | 2 | 38089586 | |
| Pubmed | 7.69e-04 | 33 | 43 | 2 | 25179941 | ||
| Pubmed | 9.67e-04 | 37 | 43 | 2 | 24742347 | ||
| Pubmed | 1.07e-03 | 39 | 43 | 2 | 29922981 | ||
| Interaction | UPK1A interactions | 1.00e-05 | 150 | 39 | 5 | int:UPK1A | |
| Interaction | KRTCAP2 interactions | 1.12e-05 | 72 | 39 | 4 | int:KRTCAP2 | |
| Interaction | TCTN2 interactions | 2.41e-05 | 304 | 39 | 6 | int:TCTN2 | |
| Cytoband | 14q11 | 7.39e-06 | 132 | 43 | 4 | 14q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q11 | 2.65e-04 | 332 | 43 | 4 | chr14q11 | |
| Cytoband | 15q25.2 | 7.55e-04 | 43 | 43 | 2 | 15q25.2 | |
| Cytoband | 2p12 | 5.43e-03 | 117 | 43 | 2 | 2p12 | |
| GeneFamily | T-cell receptor alpha locus at 14q11.2 | 3.02e-05 | 117 | 28 | 4 | 371 | |
| GeneFamily | Argonaute/PIWI family | 6.44e-05 | 8 | 28 | 2 | 408 | |
| GeneFamily | Immunoglobulin kappa locus at 2p11.2 | 7.28e-03 | 83 | 28 | 2 | 351 | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.80e-05 | 186 | 42 | 4 | e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_T-T_NK-CD4_T_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.04e-05 | 190 | 42 | 4 | 8fdf35c2ad1d325c00c00e4fcf2506341ff14537 | |
| ToppCell | BAL-Mild|BAL / Compartment, Disease Groups and Clusters | 3.17e-05 | 192 | 42 | 4 | 1a6cbf014d3f7a3fb6f53adab078c4742e7137de | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.30e-05 | 194 | 42 | 4 | f44394c8a6f86483063f2f5722f003a8a0a70254 | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.37e-05 | 195 | 42 | 4 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD4-T_reg|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.43e-05 | 196 | 42 | 4 | b60e5bf9a45c08e0ca12c7e2ac2009ea53e04f4e | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD4-CD4|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.50e-05 | 197 | 42 | 4 | 4bc76958ca12af2dd490d4865de6a92554a14656 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD4|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.57e-05 | 198 | 42 | 4 | 8d86b5c875d4663ea4d61f50a4eaff1883d97641 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 137 | 42 | 3 | 4dcb15de821439011df1bb0bbd7682d674bd725d | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 137 | 42 | 3 | c05ceeb7b483324604cb3f647d2da2b3786071b1 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_B1-4|TCGA-Thymus / Sample_Type by Project: Shred V9 | 3.10e-04 | 140 | 42 | 3 | 21e5f55a98b819d3638ec971d5029b2fcbd1ebc7 | |
| ToppCell | MS-CD4-CD8_2|MS / Condition, Cell_class and T cell subcluster | 3.72e-04 | 149 | 42 | 3 | 08fb6be5599c5988890c851ce5ac6781c319948e | |
| ToppCell | MS-CD4-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster | 3.94e-04 | 152 | 42 | 3 | b1eba2d5a6da3eeb83d40a92976e3e8751ed18ee | |
| ToppCell | NS-critical-d_16-33-Myeloid-Monocyte-derived_Macrophage|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.02e-04 | 153 | 42 | 3 | 859de35b24c5d7d73be1c213b90b43362ee2e0eb | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.17e-04 | 155 | 42 | 3 | 105d59d8a1bb8cb37eef2c1767d737b2108ac7c5 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.66e-04 | 161 | 42 | 3 | 82ed45f144a07856fe92d37426c5f92e259a03a9 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.66e-04 | 161 | 42 | 3 | dccb61d5e17a8f1c6d1fc146ee389f567659a0f0 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.83e-04 | 163 | 42 | 3 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.83e-04 | 163 | 42 | 3 | d005115aa1e1458b51de7eb719794617a4168608 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.01e-04 | 165 | 42 | 3 | 1b7dfa173e83aa8c46a3153a3261866c065c3b73 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.01e-04 | 165 | 42 | 3 | b4f7d33af7d053ec07b01bd67d861600a9c4822e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.01e-04 | 165 | 42 | 3 | e381bcd558745f3a60346f78b49d0b2672184baa | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-04 | 166 | 42 | 3 | 13027ae342994db4540e64eb910df1f42b160931 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-04 | 166 | 42 | 3 | b21e45bd43f26149b9cd6e45c19241c82d54fb2f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L5_RORB_SNHG7|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.18e-04 | 167 | 42 | 3 | 5d89f5bcd0aaa772c1d09c2cc46fbfe0a90f9f12 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.27e-04 | 168 | 42 | 3 | 217770a94ace446cdfc7687b459dece707576e76 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.27e-04 | 168 | 42 | 3 | f5a18123f84c62211d9279e9c41e90122e4c4895 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L3-5_THEMIS_UBE2F|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.27e-04 | 168 | 42 | 3 | bfa1491e8d433933003778b274710d3a16d973cb | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.27e-04 | 168 | 42 | 3 | 08f6e171a1ea5cf65149744296d0fcd6c7b9684e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBC1D26|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.37e-04 | 169 | 42 | 3 | 2abdd8ae9a5d88aac30992142d1b502c959bc015 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.46e-04 | 170 | 42 | 3 | 417b77c12a7982b1ce4b4bc57f30335d261220f5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.55e-04 | 171 | 42 | 3 | 6a489a75eeab2a2d48d604682e93599c20a945fe | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.84e-04 | 174 | 42 | 3 | e4d65fe121a32ac4cdd6312e7b8f867f0852e991 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.94e-04 | 175 | 42 | 3 | 6a093c74a6f3daeff07759d6eec542fc5c709149 | |
| ToppCell | droplet-Fat-Mat-18m-Hematologic-monocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-04 | 176 | 42 | 3 | 867936a20f73f638055c19c8d88834aa2cc657cf | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.14e-04 | 177 | 42 | 3 | 4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-04 | 177 | 42 | 3 | 9ec7f1e64312d26d434b3312b58386715dbad644 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.14e-04 | 177 | 42 | 3 | fc40918825b7e1eb6861df59dfca944778a64b98 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.14e-04 | 177 | 42 | 3 | b75f519d72611b293d9684f7dcfb1b70fbf54a90 | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 6.14e-04 | 177 | 42 | 3 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-04 | 177 | 42 | 3 | 016277dfd59b1793fddaaadc2b3f41622d76ce3a | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.14e-04 | 177 | 42 | 3 | d746122bf8d208c3aa4d156e8c12d0a0e555c6e5 | |
| ToppCell | Dividing_Macrophages-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 6.24e-04 | 178 | 42 | 3 | 1893fadac2ec3d5de0a641e57b7b2f962012a9ba | |
| ToppCell | Severe-CD4+_T_activated|World / Disease group and Cell class | 6.24e-04 | 178 | 42 | 3 | ef6111238703579a34bd6948bd9d4ca6b7e16063 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.34e-04 | 179 | 42 | 3 | 837ed81f18257f444eaeadc4fac89deedd4e3061 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.34e-04 | 179 | 42 | 3 | d70791d2a0db35a6b013fa7ed2f9f39364581eff | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 6.34e-04 | 179 | 42 | 3 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.34e-04 | 179 | 42 | 3 | 021d782134126c6f7dce6b6ea50cc54bdaa39987 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.34e-04 | 179 | 42 | 3 | b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.45e-04 | 180 | 42 | 3 | a499548391e6833b78f6e920f8e32a755814a9da | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.45e-04 | 180 | 42 | 3 | d553aba594f5304f1c09ff9c6d49b64cd7ee7850 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_B_plasma|GI_small-bowel / Manually curated celltypes from each tissue | 6.55e-04 | 181 | 42 | 3 | 9b33f531c8ac776706ec7e2d47e95ba30b6ce13c | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_B_plasma-Plasma_cells|GI_small-bowel / Manually curated celltypes from each tissue | 6.55e-04 | 181 | 42 | 3 | a0549a8c2b5b30e91fae3052f398e48baa45d7ff | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.66e-04 | 182 | 42 | 3 | 0e52ba34e179d9bfaac7b49920b44c710b2b8dad | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.66e-04 | 182 | 42 | 3 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.66e-04 | 182 | 42 | 3 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B_plasma-Plasma_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 6.76e-04 | 183 | 42 | 3 | a6866951866373a1029e04818f4a4a31278c409d | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B_plasma|lymph-node_spleen / Manually curated celltypes from each tissue | 6.76e-04 | 183 | 42 | 3 | beadc69f511cf183e493cb445135f0748ab8b20e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.76e-04 | 183 | 42 | 3 | cea27d5e0ec1145d4606c41c18de29035b4aeabe | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 6.76e-04 | 183 | 42 | 3 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.76e-04 | 183 | 42 | 3 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.87e-04 | 184 | 42 | 3 | 23515c28e1f42aab29cef9e5b4a7f45bda7f5520 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.87e-04 | 184 | 42 | 3 | e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.87e-04 | 184 | 42 | 3 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-Progenitor_(NEUROG3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.98e-04 | 185 | 42 | 3 | 2088e82e0febdcf05618d3db913d00e2e87812f4 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.98e-04 | 185 | 42 | 3 | f30fb9d75cdb757b206312992aaf7485bc900f96 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.98e-04 | 185 | 42 | 3 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.98e-04 | 185 | 42 | 3 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 6.98e-04 | 185 | 42 | 3 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | IPF-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 7.09e-04 | 186 | 42 | 3 | f9c21daf905d0bb0e0e769ca4bb069ea4b1ba25b | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_T_(gd)|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.20e-04 | 187 | 42 | 3 | e5713a7bda53d1d5178ab4e0dbadc2292b6005bc | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 7.31e-04 | 188 | 42 | 3 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 7.31e-04 | 188 | 42 | 3 | bd53b0371154cff680226897b61c9809a239d1b6 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 7.31e-04 | 188 | 42 | 3 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.31e-04 | 188 | 42 | 3 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_T-T_NK-CD8_T_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.42e-04 | 189 | 42 | 3 | 347dea83d0c612341c1ef6e5df5e369520f0a0a4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.42e-04 | 189 | 42 | 3 | 06c44746fa4f02e6e2b3b635cdf2d8dfef3754d3 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.54e-04 | 190 | 42 | 3 | 494fbab37305a7f92cddec75b291d42282555f5f | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.54e-04 | 190 | 42 | 3 | 55df73c8b696967a925b1772631f6900eff0fa30 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.54e-04 | 190 | 42 | 3 | 3b8d1e66ae68c1eee64095e75195d76d97e24026 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.54e-04 | 190 | 42 | 3 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 7.54e-04 | 190 | 42 | 3 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.54e-04 | 190 | 42 | 3 | 59720dfe9de1b980807644536c919d2a02ba69dd | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.54e-04 | 190 | 42 | 3 | dc655e4782aab274f0c9b6e36a5ce315e3a1a4b9 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.65e-04 | 191 | 42 | 3 | 2feab42ac6d29fa4eac78f3f78a5f8aa0a559523 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 7.65e-04 | 191 | 42 | 3 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 7.65e-04 | 191 | 42 | 3 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | Calu_3-infected-SARSCoV2|infected / Cell line, Condition and Strain | 7.65e-04 | 191 | 42 | 3 | 2da876d26f37a00dbdf1ee79d724306e8b20f304 | |
| ToppCell | Mild/Remission-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.65e-04 | 191 | 42 | 3 | 382686d62f7b8576c44bb9726a4e10dc26fd348e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.65e-04 | 191 | 42 | 3 | 9c0ee270209b02043393416ecc9a81ddedfbb8b6 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 7.77e-04 | 192 | 42 | 3 | 119832d4aee29ddda2485fc3e5dcdaacf833cc30 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 7.77e-04 | 192 | 42 | 3 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | COVID-19-Myeloid-MoAM1,_IL1R2|Myeloid / Condition, Lineage and Cell class | 7.77e-04 | 192 | 42 | 3 | be9d5685fa03563322f147a4b38ed31e4da59487 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.77e-04 | 192 | 42 | 3 | f6ec683b2133b3095a1fcc06ca8605cf38f774b5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.77e-04 | 192 | 42 | 3 | 690b3d17c481159bc96b8bc7f6a66b51343ee858 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.77e-04 | 192 | 42 | 3 | 8df4cfe1461819756138ff1180896238dca2787e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 7.77e-04 | 192 | 42 | 3 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 7.77e-04 | 192 | 42 | 3 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | CV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 7.77e-04 | 192 | 42 | 3 | 2a2052b44e8f679ef484f03ba4fb37b0ec841b88 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.89e-04 | 193 | 42 | 3 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| Disease | virologic response measurement, response to abacavir | 1.28e-03 | 42 | 37 | 2 | EFO_0006905, EFO_0006906 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 1.34e-03 | 43 | 37 | 2 | DOID:2476 (implicated_via_orthology) | |
| Disease | hypertension (biomarker_via_orthology) | 2.88e-03 | 227 | 37 | 3 | DOID:10763 (biomarker_via_orthology) | |
| Disease | eotaxin measurement | 4.55e-03 | 80 | 37 | 2 | EFO_0008122 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VHYNQPEWLSDFLYY | 506 | O00555 | |
| LLLYWQLQLFGNYQY | 921 | Q4VNC0 | |
| YWQNHPELHDIPIYY | 256 | Q9UKF6 | |
| YHYQATTQYLPGQWQ | 181 | Q8N9W6 | |
| SWGNNYPQHRQEPYY | 86 | Q9BTL3 | |
| WPGYDLNLFTYPQHY | 21 | Q9NRG1 | |
| HYPNELLQEYNWELA | 136 | Q05329 | |
| HSNGYNYLDWYLQKP | 51 | P01615 | |
| PLYYRYWVHSGQQVH | 661 | P50747 | |
| LQPFYYLVQQTIHWL | 416 | Q6P1A2 | |
| YYFHLQTFQGIWEQP | 681 | Q86VI3 | |
| LPPLNNYLHVFYYSW | 96 | Q5SRI9 | |
| WKTFLLYNQGPEYHY | 31 | Q9NPH5 | |
| YLNLHWANVVYYSPN | 196 | Q15165 | |
| PQVAYQYWPLAELQY | 206 | P87889 | |
| HLQWPYKYNNNTLLY | 826 | P06756 | |
| NAIQFYVPWNYHEPQ | 76 | Q6UWU2 | |
| YNGYLHPWYQKNSQA | 346 | Q96DP5 | |
| NTRHCWYNYPYQPLT | 161 | Q6ZMG9 | |
| WVAYHQYYQRPIGVL | 126 | P05108 | |
| HSNGYNYLDWYLQKP | 51 | A0A075B6P5 | |
| IIGYGIWHCYQQYTN | 281 | Q8NCS7 | |
| PAEHPLQYNYTFWYS | 51 | O60573 | |
| QWALYQYHIDYNPLM | 126 | Q96J94 | |
| LQGWYIVTYALGIYH | 61 | O15258 | |
| DFPQDWQLYQYHVTY | 116 | Q7Z3Z4 | |
| LLQNQYEPVQPHWFY | 261 | Q9Y6Y8 | |
| YAHRDGPNYQWVPYQ | 356 | Q14563 | |
| IYQNSYTWELSPHLY | 886 | O94911 | |
| YLFWYVQYPNQGLQL | 51 | P01737 | |
| YLFWYVQYPNQGLQL | 51 | A0A0B4J262 | |
| VWYQNVLPYYLNDYH | 161 | Q8IY51 | |
| QAIQWILHYYYHGVQ | 461 | Q8IZH2 | |
| QPITYNHYQYPGWAV | 596 | P48067 | |
| YWYRQIHSQGPQYII | 51 | A0A087WT03 | |
| NYYNHRTYPGLVNWL | 31 | Q6ZVL8 | |
| TWHHYVYQPKYLDQQ | 1241 | Q9ULD9 | |
| YGNPNYHWQETAYLL | 351 | Q9UMW8 | |
| GFTSWIAYYINHPLY | 226 | Q5HYJ1 | |
| NLFWYVQYPGQHLQL | 51 | A0A0A6YYK1 | |
| YRPQYGYWVIGLQNT | 401 | Q8IYM9 | |
| QLLYPWTQYYQGELH | 651 | Q96GX1 | |
| QWHYDGLHPSYLYNR | 121 | Q8WVF2 | |
| VQYQGHYYEWLPRYN | 141 | P82987 |